Needham Maintains Buy on Alkermes, Raises Price Target to $62

Benzinga Newsdesk www.benzinga.com Positive 74.0%

Neg 0% Neu 0% Pos 74%

Needham analyst Ami Fadia maintains Alkermes (NASDAQ:ALKS) with a Buy and raises the price target from $61 to $62.

Comments

No comments yet. Be the first!